Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NPM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL13AP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MICA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GORASP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CKMT1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSK3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC123 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on